Effect of sarcopenia on hospital stay from post cardiac surgery to discharge

Shibasaki, Ikuko; Ouchi, Motoshi; Fukuda, Taira; Tsuchiya, Go; Ogawa, Hideoki; Takei, Yusuke; Tezuka, Masahiro; Kanazawa, Yuta; Katayanagi, Satoshi; Nozawa, Naohiro; Mizushima, Takashi; Toyoda, Shigeru; Fukuda, Hirotsugu; Nakajima, Toshiaki

doi:10.1016/j.ijcha.2022.101003

Cited by 8 publications

(13 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…19,20 In addition, sarcopenia has been shown to be linked to prolonged postoperative hospitalization in patients undergoing cardiac surgery, and it was found that treating sarcopenia and improving patients' nutritional status had a positive effect on shortening the postoperative hospital stay. 21 In this study, psoas muscle parameters were not associated with the traditionally used risk assessment method EuroSCORE II. 17 This is logical, since the EuroSCORE II evaluates the risk of in-hospital or short-term mortality, whereas the psoas parameters are more apt in assessment of long-term mortality.…”

Section: Discussionmentioning

confidence: 51%

See 1 more Smart Citation

Computed tomography -defined sarcopenia is associated with long-term survival among patients undergoing open thoracic aortic reconstruction

Valkkio,

Kuoppala,

Lindström

et al. 2023

Scand J Surg

View full text Add to dashboard Cite

Background and objective: As markers of sarcopenia, psoas muscle areas and indexes measured from computed tomography images have been found to predict long-term mortality in cardiothoracic as well as other surgical cohorts. Our objective was to investigate the association between psoas muscle status, taking into account muscle density in addition to area, and survival among patients undergoing open thoracic aortic reconstruction. Methods: This was a retrospective registry study of a total of 451 patients treated with open surgery for thoracic aortic pathology. Psoas muscle area and density were measured from preoperative computed tomography images at the L3 and L4 lumbar levels. In addition, lean psoas muscle area was calculated by averaging sex-specific values of psoas muscle area and density. The association between mortality and psoas muscle status was analyzed with adjusted Cox-regression analysis. Results: The median age of the study population was 63 (interquartile range (IQR): 53–70) years. The majority were male (74.7%, n = 337) and underwent elective procedures (58.1% n = 262). Surgery of the ascending aorta was carried out in 90% of the patients, and 15% (n = 67) had concomitant coronary artery bypass surgery. Aortic dissection was present in 34.6% (n = 156) patients. Median follow-up time was 4.3 years (IQR: 2.2–7.4). During the follow-up, 106 patients (23.5%) died, with 55.7% of deaths occurring within the first four postoperative weeks. Psoas muscle parameters were not associated with perioperative mortality, but significant independent associations with long-term mortality were observed for psoas muscle area, density, and lean psoas muscle area with hazard ratios (HRs) of 0.63 (95% confidence interval (CI): 0.45–0.88), 0.62 (95% CI: 0.46–0.83), and 0.47 (95% CI: 0.32–0.69), respectively (all per 1-SD increase). Conclusions: Psoas muscle sarcopenia status is associated with long-term mortality after open thoracic aortic surgery.

show abstract

Section: Discussionmentioning

confidence: 51%

Section: Discussionmentioning

confidence: 99%

Computed tomography -defined sarcopenia is associated with long-term survival among patients undergoing open thoracic aortic reconstruction

Valkkio,

Kuoppala,

Lindström

et al. 2023

Scand J Surg

View full text Add to dashboard Cite

show abstract

“…8 Institute of Cardiology and Sports Medicine, Department Preventive and Rehabilitative Sport and Exercise Medicine, German Sport University, Am Müngersdorfer Sportpark 6, 50933 Cologne, Germany. 9 Department of Cardiology and Pneumology, University Medical Center Goettingen, Robert-Koch-Str. 40, 37075 Goettingen, Germany.…”

Section: Supplementary Informationmentioning

confidence: 99%

“…The prevalence of sarcopenia in older patients with cardiovascular diseases (CVD) is high (35%), compared to 13% in the general population and varies among the different cardiovascular diagnoses (e.g., cardiac arrhythmia: 35% [ 7 ]; chronic heart failure: 32% [ 7 ] to 34% [ 8 ]; coronary artery disease: 30% [ 7 ]) [ 7 ]. The highest prevalence of sarcopenia is described between 37.5% [ 9 ] and 46.4% [ 10 ] during inpatient stay after cardiac surgery [ 9 , 10 ]. The prevalence of reduced muscle mass and muscle strength in patients entering CR is high [ 11 ].…”

Section: Introductionmentioning

confidence: 99%

The prevalence and impact of sarcopenia in older cardiac patients undergoing inpatient cardiac rehabilitation – results from a prospective, observational cohort pre-study

Steinmetz,

Krause,

Sulejmanovic

et al. 2024

BMC Geriatr

View full text Add to dashboard Cite

Background The prevalence of sarcopenia and its impact in older patients undergoing inpatient cardiac rehabilitation (iCR) after cardiac procedure has been insufficiently studied. The main aim of this study was to evaluate the prevalence of sarcopenia and quantify the functional capacity of older sarcopenic and non-sarcopenic patients participating in iCR. Methods Prospective, observational cohort study within the framework of the ongoing multicenter prehabilitation study “PRECOVERY”. A sample of 122 patients ≥75 years undergoing iCR after cardiac procedure were recruited in four German iCR facilities and followed up 3 months later by telephone. At iCR (baseline), the Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls (SARC-F) questionnaire was used to identify sarcopenic patients. In addition, Katz-Index, Clinical Frailty Scale (CFS), handgrip strength (HGS), Short Physical Performance Battery (SPPB) and 6-minute walk distance (6MWD) measured functional capacity and frailty at baseline. Outcomes were prevalence of sarcopenia and the correlation of sarcopenia to functional capacity and frailty at baseline as well as the SARC-F score at follow-up. The Wilcoxon test was applied for pre-post-test analysis. Correlation between sarcopenia and 6MWD, SPPB score and HGS was tested with the eta coefficient with one-way ANOVA. Results Complete assessments were collected from 101 patients (79.9 ± 4.0 years; 63% male). At baseline, the mean SARC-F score was 2.7 ± 2.1; 35% with sarcopenia. Other baseline results were Katz-Index 5.7 ± 0.9, CFS 3.2 ± 1.4, HGS 24.9 ± 9.9 kg, SPPB score 7.5 ± 3.3 and 6MWD 288.8 ± 136.5 m. Compared to baseline, fewer patients were sarcopenic (23% versus 35%) at follow-up. In the subgroup of sarcopenic patients at baseline (n = 35), pre-post comparison resulted in a significant SARC-F improvement (p = 0.017). There was a significant correlation between sarcopenia measured by SARC-F and poor results in the assessments of functional capacity (p < 0.001; r > 0.546). Conclusions The prevalence of sarcopenia in older patients at iCR after cardiac procedure is high (35%) and remains high at follow-up (23%). Sarcopenia screening is important since the diagnosis of sarcopenia in these patients correlates significantly with poor functional capacity. The results indicate that these patients may benefit from prehabilitation aimed at improving perioperative outcomes, increasing functional capacity and mitigating adverse effects. Trial registration German Clinical Trials Register (DRKS; http://www.drks.de; DRKS00032256). Retrospectively registered on 13 July 2023.

show abstract

“…Sarkopenie byla signifi kantním faktorem pro prodlouženou dobu hospitalizace v porovnání s pacienty bez sarkopenie (31,6; SD: 33,7 vs. 22,7; SD: 20,5 dne, p < 0,001). 14…”

Section: Sarkopenieunclassified

(Frailty syndrome, what should we know before cardiac surgery)

Smolák,

Gofus,

Voborník

et al. 2023

Cor Vasa

View full text Add to dashboard Cite

Syndrom křehkosti je klinický syndrom, ve kterém jsou přítomny tři nebo více z následujících kritérií: neúmyslný úbytek hmotnosti 4,5 kg (10 liber) za poslední rok, pacientem udávaná vyčerpanost, slabá svalová síla úchopu, pomalá rychlost chůze a snížená fyzická aktivita. Prevalence křehkosti u kardiochirurgických pacientů je podle dostupných studií od 4,1 % do 46 %. Je spojený s výskytem sarkopenie a osteoporózy. Pro diagnostiku v kardiochirurgii je vhodný nástroj Edmonton Frail Scale, který je vyvinut pro negeriatrické specialisty a poskytuje informace ohledně závislosti pacienta na okolí, znalost zvládání běžných denních aktivit a úrovně fyzické zdatnosti. Existuje široká škála dalších nástrojů k hodnocení. Syndrom křehkosti je nezávislý rizikový faktor zvýšené morbidity, mortality a prodloužené doby hospitalizace po kardiochirurgické operaci. Tito pacienti mají vysoké riziko neúspěchu zvoleného terapeutického postupu. Základem péče o rizikové pacienty je screening a prevence vzniku syndromu křehkosti. Dá se mu předejít dostatečnou fyzickou aktivitou, zdravým životním stylem a pravidelným kognitivním tréninkem.

show abstract

Effect of sarcopenia on hospital stay from post cardiac surgery to discharge

Cited by 8 publications

References 30 publications

Computed tomography -defined sarcopenia is associated with long-term survival among patients undergoing open thoracic aortic reconstruction

Computed tomography -defined sarcopenia is associated with long-term survival among patients undergoing open thoracic aortic reconstruction

The prevalence and impact of sarcopenia in older cardiac patients undergoing inpatient cardiac rehabilitation – results from a prospective, observational cohort pre-study

(Frailty syndrome, what should we know before cardiac surgery)

Contact Info

Product

Resources

About